Region I Annual Conference May 23-27, 2024 Half Moon, Montego Bay, Jamaica A Mind is a Terrible Thing to Waste: From Development to Dementia, Intersections of Brain Health and Mental Health
2024 REGION I ANNUAL MEDICAL CONFERENCE MAY 23 – 27, 2024 HALFMOON HOTEL MONTEGO BAY, JAMAICA A Mind is a Terrible Thing to Waste: From Development to Dementia, Intersections of Brain Health and Mental Health
NATIONAL MEDICAL ASSOCIATION 2 2024 REGION I ANNUAL CONFERENCE CONNECTICUT Cato Laurencin, MD President Imhotep Connecticut NMA Society laurencin@uchc.edu MAINE Jims Jean-Jacques, MD President Maine Medical Society jimsjj@yahoo.com MASSACHUSETTS Ellana Stinson, MD Acting President New England Medical Association estinson@nema-nma.org NEW JERSEY Damali Oparaji, MD President New Jersey Medical Association campbedm@njms.rutgers.edu U.S. VIRGIN ISLANDS Brian Bacot, MD bbacot1@mac.com Vimedicalsociety@hotmail.com NEW YORK William Gibbs, MD President Empire State Medical Association drgibbs@goageless.com Glen McWilliams, MD President Manhattan Central Medical Society gudoc99@gmail.com Karen Myrie, MD President Susan Smith McKinney Steward Medical Society ssmsmedicalsociety@gmail.com Donald Moore, MD President Provident Clinical Society of Brooklyn dondoc007@aol.com Liat Applewhite, MD (inactive) President Clinical Society of Queens and Long Island liatapple@gmail.com presidentcsqli@gmail.com Brian Harper, MD, MPH President Arthur T. Risbrook Society bharper@nyit.edu Fred Archer, MD President NMA Buffalo Affiliate Dr. Alexandria Bastien, MD President Westchester & Bronx Society of Black Physicians Westchesterbronx.bp@gmail.com REGION I REPRESENTATION Guirlaine Agnant, MD Region 1 Chair Monique De Four Jones, MD, MBA Region 1 Vice Chair Gwendolyne Jack, MD Region 1 Secretary Candace Tannis, MD, MPH Treasurer Donna Kiel, MD Scientific Program Chair Camille A. Clare, MD, M.P.H. Region 1 Trustee Damali Campbell-Oparaji, MD Region 1 Trustee Juana Hutchinson-Colas, MD, MBA Region 1 Corporate Trustee Vashti Henriques, MBA, CMP Administrator NMA REGION I LEADERSHIP Connecticut Maine Massachusetts New Hampshire New Jersey New York Puerto Rico Rhode Island Vermont United States Virgin Islands NMA REGION I AFFILIATES
2024 REGION I ANNUAL CONFERENCE 3 NATIONAL MEDICAL ASSOCIATION Welcome from the 124th NMA President May 2024 Greetings Esteemed Colleagues! It is a pleasure for me to welcome you to the Region I Annual Meeting! The Region I leadership has put together an exciting, relevant and timely program. This meeting will inform, educate, and equip attendees with the tools necessary to empower Black physicians to challenge the status quo, and give a voice to the most vulnerable patient populations as we move the needle forward in the elimination of health disparities. We know that just about every facet of health care affects Black Americans disproportionally. I applaud Region I for their focus and theme of this meeting, “A Mind is a Terrible Thing to Waste: From Development to Dementia, Intersections of Brain Health and Mental Health.” Brain health as a pathway to better mental health is multi-faceted and requires addressing all of the social determinants of health that play a significant role in mental wellness. The barriers that minority communities face in adopting brain healthy lifestyles is directly related to the socio-economic and environmental factors that influence the health and wellness of these communities on a daily basis. As the NMA continues to work on the elimination of health disparities, we must support solutions that support building and maintaining cognitive health and resilience. As we continue the fight for health equity, we must be transformative in our efforts, our thinking and our approach. This meeting will reinforce our commitment to the well-being of our patients, as well as those vulnerable and disadvantaged populations. The NMA remains the leading voice for parity and justice in medicine, for us and the patients we serve. I am very proud of the work that we are all doing to advance health equity. We continue to be the trusted messengers for our community and we remain vigilant in our efforts to speak to the specific needs and concerns of African Americans. Thank you for your continued support of the National Medical Association. Sincerely, Yolanda Lawson, MD Welcome from the 124th NMA President
NATIONAL MEDICAL ASSOCIATION 4 2024 REGION I ANNUAL CONFERENCE
2024 REGION I ANNUAL CONFERENCE 5 NATIONAL MEDICAL ASSOCIATION Welcome to the 2024 Annual Scientific Meeting of Region I of the National Medical Association (NMA). We are happy to have this year’s meeting in-person at the Half Moon Resort in Montego Bay, Jamaica. The planning committee has created an informative and thought-provoking program for physicians and other healthcare professionals. Our regional educational program focuses primarily on Mental Health and Brain Health and where they intersect for us as providers and for our patients. The impact and care of these areas can not be limited to the purview of one or two specialties that we consult. Over the ages and stages of our patients’ lives and of our own, alterations and derangements in these leaves very few untouched. We come together again as a community in a post-pandemic world that has compelled us to address so many aspects of our lives differently. Prior to the pandemic, we were seeing increased rates of mood disorders and anxiety across most age groups along with devastating increases in rates of Suicides particularly for adolescent black males.With our persistent lens on Health Equity, we are narrowing in on Mental Health and Brain Health for our presentations. Last year, we explored how societal forces and policies that determined where we and our ancestors lived, worked, and were educated, resulted in so much of the inequity and vulnerability we experience presently. We also saw that the National Medical Association in collaboration with other national organizations helped to lead us forward. This work continues as we are calling on the current administration to ban Menthol tobacco products and to support and protect birthing persons and babies. During our time together, we will explore how families cope with and manage the landscape of having children with developmental disorders. We will learn how they seek interventions that support dignity and success in the present and future. We will look more deeply into perinatal mental health. The mental health impact of the ‘change’ will be fleshed out beyond vasomotor symptoms and a loss of fertility. Some of our presenters will guide us through the biological and psychiatric impact of racism-based trauma and stress. There will be an exciting panel about how any of these phenomena and others shift family dynamics and wellness. While rates of addiction are increasing, we will see that it is not in tandem with equitable or proportionate access and utilization for recovery resources. With increased Stroke survival across all populations, we will explore what this means for quality of life and brain health going forward. Our brain health leaves no area of our lives untouched from our choice of breakfast to our choice of health plan. Each of us can play a role in improving outcomes whether learning where to best refer our patients, finding space to be those eyes and ears that really validate patients or working with any governing agency to add our voices to the decision-making on these concerns. As always, I hope this conference provides each of us an opportunity to see one another and learn our stories. We thank the national office of the National Medical Association and the Department of Continuing Medical Education for their guidance and support of the regional educational programs. We also thank our speakers and members for their commitment and support of this educational program. We are indebted to the sponsors whose generosity makes this conference possible. Finally, I deeply thank the Region 1 leadership, planning committee, and National Leadership for their collaboration, support and guidance. Warm regards, Donna Kiel, M.D. Scientific Program Chair
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow® disease to deliver better patient outcomes. Learn more about what we do: Lantheus.com Connect with us on social media: @Lantheus @LantheusNews
2024 REGION I ANNUAL CONFERENCE 7 NATIONAL MEDICAL ASSOCIATION Supported in part by educational and research grants from: National Dairy Council UNRESTRICTIVE SUPPORT Hologic, Inc. SPECIAL THANKS TO: National Dairy Council Hologic, Inc Multicultural Healthcare Marketing Group Taylor Insurance and Financial Services Lantheus Consumers for Dental Choice Clean Water Acknowledgements
NATIONAL MEDICAL ASSOCIATION 8 2024 REGION I ANNUAL CONFERENCE Activity Overview/Description: This two-day meeting will feature dynamic and enriching sessions and panel discussion on topics that include mental illness in the African American community and recommendations, treatment and support of mental illness. Target Audience: This activity is intended for Physicians, Physician Assistants, Podiatrists, and Nurse Practitioners. Accreditation Statement: The National Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement: The National Medical Association designates this live in-person activity for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Learning Objectives: • Discuss the scope of prevalence and impact of mental illness in the African American community. • Describe the range of developmental and disease processes included in mental illness. • Outline ways to improve recognition of mental and Brian illness presentations across various ages and stages. • Discuss resources for referrals and recommendations for diagnosis, treatment and support. • Identify the range of patients and caregivers at risk for Mental Illness and Compromised Brian health. Unapproved Use of Disclosure: Please note that this activity may contain discussions of unlabeled uses of FDA-approved products, AND/OR discussions of investigational products not yet approved by the FDA. Please refer to the official prescribing information for approved indications, contraindications, and warnings. Summary of Planning/Faculty Disclosure: In accordance with the ACCME’s Standards for Integrity and Independence, all persons who control the educational content of NMA accredited activities must disclose all financial relationships with any ineligible companies that they have had over the past 24 months. NMA uses the ACCME’s definition of ineligible companies: Those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients. There is no minimum financial threshold. NMA determines whether any of these relationships is relevant to this activity. All the relevant financial relationships identified for persons in a position to control activity content have been mitigated. The following planners, moderators, and speakers declare no relevant relationship with commercial entities. • Gurilaine Agnant, MD • Paul T. Alexander, MD, MPH • Charletta Ayers, MD, MPH • Taiwo Alonge, MD • Rahn Bailey, MD • Karen Bell, MD • Carolyn Britton, MD • Doris Browne, MD • Joy Calloway, MBA, MHSA • Jewell Crawford, MD • Wendi El-Amin, MD • Francene Gayle, MD • Kimberly Grocher, PhD • Terrell Holloway, MD • Monique James, MD • Ashanda Saint Jean, MD • Monique De Four Jones, MD, MBA, MS • Donna Kiel, MD • Stephanie LeMelle, MD • Patricia Marsh, MD • Mark Mitchell, MD • Ted Obi, MD • Aderonke Ramos, MD • Georgia Rose, M.Sc. • Jiles Ship • Candace Tannis, MD, MPH The following planners, moderators, and speakers declare the following relations with commercial entities. • Grace Forde, MD: Abbvie- Speaker • Yolanda Lawson, MD: AbbVie- Speaker; Myovant ScienceSpeaker; Pfizer- Advisory Group; Viiv- Advisory Grou • Winston Price, MD: NDA- Speaker; RAI-Consultant; Republica- Speaker • Nyamekye Richards, MBBS: Medipex LTD- Speaker • Sheila Thorne: Amgen-Consultant; Diageo- Consultant; Neuron Therapeutics- Clinical Trials; RAI- Consultant • Jennifer Walton, MD: Pri-Med- Speaker Disclaimer: National Medical Association and their staff are not responsible for injury or illness resulting from the use of medications or modalities discussed during this educational activity. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgement of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Instructions to Receive Credit: Participants must view the CME materials, attend the live activity and complete and submit the evaluation and return the completed CME Credit Attestation form. Statement of Credit and Purpose
2024 REGION I ANNUAL CONFERENCE 9 NATIONAL MEDICAL ASSOCIATION THURSDAY MAY 23, 2024 4:00 - 6:00 pm Arrivals/Registration AFTERNOON SESSION Room: Rose Hall & St. James 4:05 - 4:10 pm Opening Remarks Guirlaine Agnant, MD 4:10 - 4:20 pm Welcome Representative from The Ministry of Health and Wellness 4:20 - 4:50 pm Introduction of Speaker Monique De Four Jones, MD Mental Health Service Delivery - From Infancy to Adulthood, a Jamaican Perspective Georgia Rose, M.Sc. 4:50 -5:00 pm Questions and Answers/Discussion 5:00 - 5:10 pm Closing Remarks and Announcements 5:15 - 6:30 pm Break/Registration/Visit Exhibits 6:30 - 9:00 pm OPENING RECEPTION/ WELCOME Location: Seagrape Restaurant Welcome: Guirlaine Agnant, MD, Region I Chair Remarks: Tourism Board Representative Greetings: Auxiliary to the National Medical Association - Vivienne Hewitt, Esq Greetings on Behalf of National Office and our 124th President FRIDAY MAY 24, 2024 7:45 - 8:10 am Registration/Buffet Breakfast Room: Montego Room MORNING SESSION Room: Rose Hall and St. James Moderator: Monique De Four Jones, MD 8:10 - 8:20 am Welcome/Announcements 8:25 - 8:45 am Why Mental Health Now? Donna Kiel, MD 8:45 - 9:10 am The Role of Providers in Eliminating Disparities in Intellectual & Developmental Disabilities Winston Price, MD 9:15 - 9: 40 am Child Development & Behavior: A Review & Relevance In Our Communities Jennifer Walton, MD 9:45 - 10:10 am Is Almost Everybody on the Spectrum? What is Neurodivergence? Nyamekye Richards, MBBS 10:15 - 10:40 am Understanding and Overcoming Perinatal Mood Disorders Charletta Ayers, MD 10:40 - 10:50 am Break 10:50 - 11:15 am Menopause: The Reality and Impact of Vasomotor Symptoms and Pathways that Lead to Wellness Ashanda Saint Jean, MD 11:20 - 11:45 am The Role of Dairy Food Intake for Improving the Health Among Black Americans Across the Life Continuum Winston Price, MD Break/Visit Exhibits - Montego Room Program Agenda
NATIONAL MEDICAL ASSOCIATION 10 2024 REGION I ANNUAL CONFERENCE 11:55 - 12:55 LUNCHEON PROGRAM: Room: Montego Room Multicultural Healthcare Marketing Group Sheila Thorne AFTERNOON SESSION Room: Rose Hall and St. James Moderator: Damali M. Campbell-Oparaji, MD 1:10 - 1:20 pm Dental Mercury in Federal Government Programs Mark Mitchell, MD 1:20 - 1:40 pm Environmental Neurotoxins Jewell Crawford MD 1:45 - 2:10 pm Mental Health Impact of Climate Change Doris Browne, MD 2:15 - 2:35 pm Understanding the Type and Role of Psychotherapy Utilized in PsilocybinAssisted Psychotherapy for Depressive Disorders: A Qualitative Review of the Literature Ted Obi, MD, MBA, MS (poster presentation) 2:40 - 3:05 pm The Opioid Crisis in Populations of African Descent Rahn Bailey, MD 3:10 - 3:35 pm Suicide and Adolescent Black Males Taiwo Alonge, MD 3:40 - 4:05 pm Invisible Wounds: Understanding How Stress and Trauma Impact Health and Aging Terrell Holloway, MD 4:10 - 4:15pm Wrap-up, Announcements, Free Time SATURDAY MAY 25, 2024 7:45 am Breakfast/Registration Room: Montego Room MORNING SESSION Rooms: Montego, Rose Hall and St. James 8:10 - 8:15 am Welcome Candace Tannis, MD, MPH Moderator: Donna Kiel, MD 8:15 - 8:30 am President’s Corner Yolanda Lawson, MD 124th President of the National Medical Association 8:35 - 9:20 am Panel–Stemming the Tide on Mental Health, Trauma, Substance Use Disorders and Violence Rahn K. Bailey, MD Winston Price, MD Sheila Thorne Commissioner Jiles Ship 9:25 - 9:50 am The Intersection of Mental Health in the African American Community and the Legal System Wendi El-Amin, MD 9:55 - 10:20 am The Relationship Between Grief & Trauma: Understanding & Navigating the Overlaps Kimberly Grocher, PhD 10:25 - 10:50 am Anxiety Associated with Radiologic Imaging- Can We Help? Aderonke Ramos, MD 10:55 - 11:15 am Moderator: Donna Kiel, MD Panel–Family Dynamics: Chronic Illness and Mental Health Kimberly Grocher, PhD Wendi El-Amin, MD Aderonke Ramos, MD Moderator: Karen Bell, MD Program Agenda Continued
2024 REGION I ANNUAL CONFERENCE 11 NATIONAL MEDICAL ASSOCIATION 11:20 - 11:45 am Loss of Brain Health: HIV, CKD, Anesthesia, and Beyond Carolyn Britton, MD 11:50 am-12:15 pm Neuropsychiatric Sequelae: Cardiovascular, Cerebrovascular Disease, Stroke Francene Gayle, MD 12:20 - 1:20 pm Lunch Taylor Insurance and Financial Services Room: Montego Room 1:25 - 1:50 pm Neurocognitive Decline/Dementia: Inevitability or Missed Opportunity Grace Forde, MD 1:55 - 2:20 pm End of Life Care: Navigating Perspective Shifts and Recognizing How Culture Influences the Journey Monique James, MD 2:25 - 2:50 pm The Four Factor Model of Systems Based Practice: A Tool for Teamwork and Management Dr. Stephanie LeMelle 2:55 - 3:20 pm Brain Health Equity Paul T. Alexander, MD 3:25 - 3:50 pm Cognitive Connections: Unraveling the Interplay of Brain Health, Mental Wellness, and Digital Literacy Patricia Marsh, MD Closing and Thanks 4:30 - 5:30 pm Business Meeting Room: Montego Room 6:30 - 8:30 pm Chair’s Dinner Location: Royal Pavilion Terrace & Lawn
NATIONAL MEDICAL ASSOCIATION 12 2024 REGION I ANNUAL CONFERENCE Guirlaine Agnant, MD Region I, Chair Chair of Gynecology Department Montefiore Mount Vernon Hospital Mount Vernon, New York Paul Alexander, MD, MPH Executive Vice President, Chief Health Equity and Transformation Officer Adjunct Assistant Professor RWJ Barnabas Health West Orange, New Jersey Taiwo Alonge, MD, MPH Resident Physician Department of Psychiatry Yale University School of Medicine New Haven, Connecticut Charletta Ayers, MD, MPH Vice Chair of Clinical Services, Department of Obstetrics, Gynecology and Reproductive Sciences Assistant Dean of Multicultural Affairs Robert Wood Johnson Medical School New Brunswick, New Jersey Rahn Bailey, MD, FAPA, ACP 113th President of the National Medical Association Chair, Department of Psychiatry Assistant Dean of Diversity and Community Engagement LSUHSC-New Orleans New Orleans, Louisiana Karen L. Bell, MD Professor of Neurology at CUMC Columbia University Irving Medical Center Taub Institute for Research on Alzheimer’s Disease New York, New York Carolyn Britton, MD 109th President of the National Medical Association Associate Professor of Neurology Columbia University Irving Medical Center New York, New York Doris Browne, MD, MPH 118th President of the National Medical Association President and CEO Browne and Associates, LLC Co-Chair, NMA Environmental Commission Washington, District of Columbia Damali M. Campbell-Oparaji, MD Associate Professor Department of Obstetrics, Gynecology and Reproductive Health Newark, New Jersey Jewell Crawford, MD Medical Officer at Center for Disease Control and Prevention Instructor, Morehouse School of Medicine Atlanta, Georgia Monique De Four Jones, MD, MBA, MS Region I Vice Chair Associate Chief of Labor and Delivery Long Island Jewish Medical Center Director, Diversity Equity & Inclusion for Ob/Gyn Service Line Wendi El-Amin, MD Associate Dean for Equity, Diversity and Inclusion Southern Illinois University School of Medicine. Springfield, Illinois Grace Forde, MD Director of Neurological Services North American Partners Valley Stream, New York Francene Gayle, MD, FCSC-E Chief Medical Officer, Andrews Memorial Hospital Adjunct Assistant Professor of Neurology, Johns Hopkins School of Medicine Kingston, Jamaica, West Indies Kimberly Grocher, PhD, MA, LCSW Founder & CEO Life by Design Psychotherapy PLLC Clinical Assistant Professor of Social Work in Psychiatry Weill-Cornell Medical College|/NY Presbyterian Hospital Senior Lecturer in Social Work Columbia University School of Social Work Bronxville, New York Terrell Holloway, MD Clinical Neuroscience Research Unit Chief Neuroscience Research Training Program (NRTP) Fellow Yale/New Haven Hospital New Haven, Connecticut Monique James, MD Anesthesiologist/Intensivist at Memorial Sloan Kettering Cancer Center Cranford, New Jersey Faculty
2024 REGION I ANNUAL CONFERENCE 13 NATIONAL MEDICAL ASSOCIATION Ashanda Saint Jean, MD Chair, Obstetrics and Gynecology at Health Alliance Hospitals Kingston, New York Donna L. Kiel, MD Region I, Scientific Program Chair Anesthesiologist New York, New York Yolanda Lawson, MD 124th President of the National Medical Association Founder MadeWell Obstetrics and Gynecology Dallas, Texas Stephanie LeMelle, MD, MS Director of Public Psychiatry Education Columbia University Department of Psychiatry New York, New York Patricia Marsh, MD Chief Executive Officer Ask Me Your MD Inc Atlanta, Georgia Mark Mitchell, MD, MPH Professor Emeritus, Climate Change, Energy, and Environmental Health George Mason University Hartford, Connecticut Ted Nnamno Obi, MD, MBA, MS Icahn School of Medicine at Mount Sinai New York, New York Winston Price, MD 105th President of the National Medical Association Associate Professor of Pediatrics Philadelphia College of Osteopathic Medicine, South Georgia Campus Bainbridge, Georgia Aderonke Ramos, MD Medical Director, Northwell Health Radiology Assistant Professor, Department of Radiology Zucker School of Medicine at Hofstra Brooklyn, New York Nyamekye A. N. Richards, MBBS UWI Mona Psychiatrist and Adjunct Lecturer The University of the West Indies (UWI) Mona Campus Georgia Rose, M.Sc. Snr. Clinical Psychologist Montego Bay, Jamaica, West Indies Jiles Ship, MA Commissioner- New Jersey Police Training Edison, New Jersey Candace Tannis, MD, MPH Assistant Professor Department of Environmental Medicine and Climate Science Icahn School of Medicine at Mount Sinai New York, New York Eszylfie Taylor Taylor Insurance and Financial Services President Pasadena, California Sheila Thorne Multicultural Healthcare Marketing Group LLC President & CEO White Plains, New York Jennifer Walton, MD, MPH, FAAP Section Chief of Developmental and Behavioral Pediatrics Associate Professor of Clinical Pediatrics University of Miami Miller School of Medicine, Miami, Florida
NATIONAL MEDICAL ASSOCIATION 14 2024 REGION I ANNUAL CONFERENCE ABSTRACT TITLE: Understanding the Type and Role of Psychotherapy Utilized in Psilocybin-Assisted Psychotherapy for MDD: a Qualitative Review of the Literature ABSTRACT: Recent explorations into the therapeutic potential of psilocybin-assisted psychotherapy (PAP) for major depressive disorder (MDD) have highlighted its promising outcomes. This qualitative review aims to dissect the psychotherapeutic methodologies accompanying psilocybin administration, identifying the core psychotherapeutic principles that augment its efficacy. Through a meticulous survey of the literature, including randomized trials and open-label studies, we unravel the nuances of psychotherapeutic interventions employed across various studies focusing on treatment-resistant depression (TRD) and MDD. Our analysis delineates the psychotherapy types—ranging from nondirective approaches to structured integration sessions—and their pivotal role in the success of PAP. The review emphasizes preparatory sessions’ significance in building rapport and setting intentions, dosing sessions’ therapeutic environment for introspection, and integration sessions’ essentiality for assimilating psychedelic experiences. Despite methodological variations, a consistent theme emerges: the synergistic effect of psilocybin and psychotherapy significantly reduces depressive symptoms, highlighting the importance of a tailored psychotherapeutic approach. Challenges such as small sample sizes and study design limitations are discussed, alongside the call for more rigorous future research to solidify these findings. Ultimately, this review contributes to understanding PAP’s therapeutic principles, offering insights for optimizing treatment protocols and advancing clinical practice in psychedelic-assisted therapy for MDD and TRD. Poster Abstract
2024 REGION I ANNUAL CONFERENCE 15 NATIONAL MEDICAL ASSOCIATION Notes
NATIONAL MEDICAL ASSOCIATION 16 2024 REGION I ANNUAL CONFERENCE
Save the Date 2025 NMA REGION I ANNUAL MEETING May 22-25, 2025
Milk, cheese and yogurt provide protein, vitamins and minerals that help nourish brains, bones and bodies. Introducing unsweetened yogurt, cottage cheese or shredded and melted cheeses can familiarize baby to new tastes and textures. Pairing yogurt and cheese with pureed or safely prepared fruits and vegetables can help them learn to like a variety of foods and build healthy habits. After baby’s first birthday, add whole dairy milk, which is an important source of calories, fat and essential nutrients to fuel brain development and growth spurts. In fact, health experts* agree dairy milk and water should be the go-to beverages for children ages 1-5 years. CONCERNED ABOUT LACTOSE INTOLERANCE? There are lactose-free and lower lactose dairy options so your child doesn’t have to miss out on the nutrition in dairy foods. Lactose-free milk is real dairy milk, just without the lactose. Hard cheeses like Cheddar, Swiss and Colby have very little lactose and the probiotics in yogurt help break down lactose making it easier to digest. How much dairy? 6-12 MONTHS 1-2 YEARS 2-3 YEARS 4-8 YEARS 9+ YEARS Introduce cheese and yogurt. No dairy milk. 1 2/3 to 2 cups total dairy/day (milk, cheese or yogurt) 2-2 1/2 cups total dairy/day (milk, cheese or yogurt) 2 1/2 cups total dairy/day (milk, cheese or yogurt) 3 cups total dairy/day (milk, cheese or yogurt) *Healthy Drinks, Healthy Kids. A Consensus of American Academy of Pediatrics, American Heart Association, Academy of Nutrition and Dietetics and American Association of Pediatric Dentistry. 6 MONTHS 12 MONTHS Note: Individuals are encouraged to obtain personalized health and medical advice from their pediatrician. SCAN TO LEARN MORE Milk, cheese and yogurt provide protein, vitamins and minerals that help nourish brains, bones and bodies. Introducing unsweetened yogurt, cottage cheese or shredded and melted cheeses can familiarize baby to new tastes and textures. Pairing yogurt and cheese with pureed or safely prepared fruits and vegetables can help them learn to like a variety of foods and build healthy habits. After baby’s first birthday, add whole dairy milk, which is an important source of calories, fat and essential nutrients to fuel brain development and growth spurts. In fact, health experts* agree dairy milk and water should be the go-to beverages for children ages 1-5 years. CONCERNED ABOUT LACTOSE INTOLERANCE? There are lactose-free and lower lactose dairy options so your child doesn’t have to miss out on the nutrition in dairy foods. Lactose-free milk is real dairy milk, just without the lactose. Hard cheeses like Cheddar, Swiss and Colby have very little lactose and the probiotics in yogurt help break down lactose making it easier to digest. How much dairy? 6-12 MONTHS 1-2 YEARS 2-3 YEARS 4-8 YEARS 9+ YEARS Introduce cheese and yogurt. No dairy milk. 1 2/3 to 2 cups total dairy/day (milk, cheese or yogurt) 2-2 1/2 cups total dairy/day (milk, cheese or yogurt) 2 1/2 cups total dairy/day (milk, cheese or yogurt) 3 cups total dairy/day (milk, cheese or yogurt) *Healthy Drinks, Healthy Kids. A Consensus of American Academy of Pediatrics, American Heart Association, Academy of Nutrition and Dietetics and American Association of Pediatric Dentistry. 6 MONTHS 12 MONTHS Note: Individuals are encouraged to obtain personalized health and medical advice from their pediatrician. SCAN TO LEARN MORE Milk, cheese and yogurt provide protein, vitamins and minerals that help nourish brains, bones and bodies. Introducing unsweetened yogurt, cottage cheese or shredded and melted cheeses can familiarize baby to new tastes and textures. Pairing yogurt and cheese with pureed or safely prepared fruits and vegetables can help them learn to like a variety of foods and build healthy habits. After baby’s first birthday, add whole dairy milk, which is an important source of calories, fat and essential nutrients to fuel brain development and growth spurts. In fact, health experts* agree dairy milk and water should be the go-to beverages for children ages 1-5 years. CONCERNED ABOUT LACTOSE INTOLERANCE? There are lactose-free and lower lactose dairy options so your child doesn’t have to miss out on the nutrition in dairy foods. Lactose-free milk is real dairy milk, just without the lactose. Hard cheeses like Cheddar, Swiss and Colby have very little lactose and the probiotics in yogurt help break down lactose making it easier to digest. How much dairy? 6-12 MONTHS 1-2 YEARS 2-3 YEARS 4-8 YEARS 9+ YEARS Introduce cheese and yogurt. No dairy milk. 1 2/3 to 2 cups total dairy/day (milk, cheese or yogurt) 2-2 1/2 cups total dairy/day (milk, cheese or yogurt) 2 1/2 cups total dairy/day (milk, cheese or yogurt) 3 cups total dairy/day (milk, cheese or yogurt) *Healthy Drinks, Healthy Kids. A Consensus of American Academy of Pediatrics, American Heart Association, Academy of Nutrition and Dietetics and American Association of Pediatric Dentistry. 6 MONTHS 12 MONTHS Note: Individuals are encouraged to obtain personalized health and medical advice from their pediatrician. SCAN TO LEARN MORE Milk, cheese and yogurt provide protein, vitamins and minerals that help nourish brains, bones and bodies. Introducing unsweetened yogurt, cottage cheese or shredded and melted cheeses can familiarize baby to new tastes and textures. Pairing yogurt and cheese with pureed or safely prepared fruits and vegetables can help them learn to like a variety of foods and build healthy habits. After baby’s first birthday, add whole dairy milk, which is an important source of calories, fat and essential nutrients to fuel brain development and growth spurts. In fact, health experts* agree dairy milk and water should be the go-to beverages for children ages 1-5 years. CONCERNED ABOUT LACTOSE INTOLERANCE? There are lactose-free and lower lactose dairy options so your child doesn’t have to miss out on the nutrition in dairy foods. Lactose-free milk is real dairy milk, just without the lactose. Hard cheeses like Cheddar, Swiss and Colby have very little lactose and the probiotics in yogurt help break down lactose making it easier to digest. How much dairy? 6-12 MONTHS 1-2 YEARS 2-3 YEARS 4-8 YEARS 9+ YEARS Introduce cheese and yogurt. No dairy milk. 1 2/3 to 2 cups total dairy/day (milk, cheese or yogurt) 2-2 1/2 cups total dairy/day (milk, cheese or yogurt) 2 1/2 cups total dairy/day (milk, cheese or yogurt) 3 cups total dairy/day (milk, cheese or yogurt) *Healthy Drinks, Healthy Kids. A Consensus of American Academy of Pediatrics, American Heart Association, Academy of Nutrition and Dietetics and American Association of Pediatric Dentistry. 6 MONTHS 12 MONTHS Note: Individuals are encouraged to obtain personalized health and medical advice from their pediatrician. SCAN TO LEARN MORE